Feifei Yang
Impact in
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Immunology 12
- Immune Cell Function and Interaction 7
- Immune cells in cancer 7
- Immunotherapy and Immune Responses 4
-
- RNA Interference and Gene Delivery 4
- Co-authors
- Andrew Z. Wang (7 shared papers)Guoguang Zheng (12 shared papers)Xiao Yang (12 shared papers)Kyle C. Roche (4 shared papers)Yu Mi (6 shared papers)Rong Wang (11 shared papers)Wenli Feng (9 shared papers)Lina Wang (9 shared papers)
- Journals
- Journal of Controlled Release (4 papers)Advanced Materials (2 papers)Molecular Immunology (2 papers)Advanced Science (2 papers)Blood (1 paper)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Feifei Yang
31 papers receiving 873 citations
Peers
Comparison fields: 5 of 77
- Immunology 333
- Biomaterials 214
- Hematology 115
- Oncology 209
- Pharmaceutical Science 45
Countries citing papers authored by Feifei Yang
This map shows the geographic impact of Feifei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Yang more than expected).
Fields of papers citing papers by Feifei Yang
This network shows the impact of papers produced by Feifei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Yang. The network helps show where Feifei Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 182 | |
| 2 | 2017 | 84 | |
| 3 | 2019 | 65 | |
| 4 | 2013 | 59 | |
| 5 | 2021 | 57 | |
| 6 | 2017 | 54 | |
| 7 | 2018 | 44 | |
| 8 | 2014 | 39 | |
| 9 | 2017 | 31 | |
| 10 | 2020 | 28 | |
| 11 | 2019 | 23 | |
| 12 | 2022 | 23 | |
| 13 | 2020 | 22 | |
| 14 | 2018 | 21 | |
| 15 | 2016 | 18 | |
| 16 | 2017 | 17 | |
| 17 | 2017 | 15 | |
| 18 | 2016 | 13 | |
| 19 | 2015 | 13 | |
| 20 | 2021 | 12 |
About Feifei Yang
Feifei Yang is a scholar working on Immunology, Molecular Biology, Oncology, Biomedical Engineering and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 880 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), Immune cells in cancer (7 papers), Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (4 papers), CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (4 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Immunology (333 citations), Biomaterials (214 citations), Hematology (115 citations), Oncology (209 citations) and Pharmaceutical Science (45 citations). Feifei Yang has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Andrew Z. Wang, Guoguang Zheng, Xiao Yang, Kyle C. Roche, Yu Mi, Rong Wang, Wenli Feng, Lina Wang, Yanfei Qi and Christof C. Smith. Their work appears in journals such as Journal of Controlled Release, Advanced Materials, Molecular Immunology, Advanced Science and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.